Literature DB >> 6628386

Isolation and structural characterization of five major sialyloligosaccharides and a sialylglycopeptide from normal human urine.

J Parkkinen, J Finne.   

Abstract

Five major sialyloligosaccharides and a sialylglycopeptide have been isolated from normal human urine by charcoal adsorption, gel filtration, ion-exchange chromatography, and paper chromatography. Structural studies including gas-liquid chromatography of monosaccharide and disaccharide derivatives, methylation analysis, glycosidase treatments, and CrO3 oxidation indicated the following structures for the compounds: 1, NeuAc(alpha 2-6)Gal(beta 1-4)Glc; 2, NeuAc(alpha 2-6)Gal(beta 1-4)GlcNAc; 3, NeuAc(alpha 2-3)Gal(beta 1-4)Glc; 4, NeuAc(alpha 2-3)Gal(beta 1-4) GlcNAc; 5, NeuAc(alpha 2-3)Gal(beta 1-3) [Neu-Ac(alpha 2-6)]GalNAc; and 6, NeuAc(alpha 2-3)Gal(beta 1-3) [NeuAc(alpha 2-6)]GalNAc (alpha 1-O)Ser. Compounds 4, 5, and 6 have not been described in a free form before. The presence of compound 5 in urine may suggest that it derives from glycoproteins through a catabolic pathway involving cleavage of the carbohydrate-peptide linkage by an endo-N-acetylgalactosaminidase. The predominating sialyloligosaccharides in urine were compounds 3 and 4. The predominance of the compounds with the sialyl(alpha 2-3) linkage is of interest in view of the recent discovery of uropathogenic Escherichia coli strains with binding specificity for sialyl(alpha 2-3)galactosides.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628386     DOI: 10.1111/j.1432-1033.1983.tb07749.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  The cellular form of human fibronectin as an adhesion target for the S fimbriae of meningitis-associated Escherichia coli.

Authors:  A Sarén; R Virkola; J Hacker; T K Korhonen
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins.

Authors:  J Parkkinen; R Virkola; T K Korhonen
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

3.  Binding characteristics of Escherichia coli adhesins in human urinary bladder.

Authors:  R Virkola; B Westerlund; H Holthöfer; J Parkkinen; M Kekomäki; T K Korhonen
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

4.  Significance of serum and urine neuraminidase activity and serum and urine level of sialic acid in diabetic nephropathy.

Authors:  Jamshid Roozbeh; Ahmad Merat; Farahnaz Bodagkhan; Raha Afshariani; Hooman Yarmohammadi
Journal:  Int Urol Nephrol       Date:  2011-01-05       Impact factor: 2.370

5.  Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis.

Authors:  T K Korhonen; M V Valtonen; J Parkkinen; V Väisänen-Rhen; J Finne; F Orskov; I Orskov; S B Svenson; P H Mäkelä
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

6.  Enzymic synthesis, chemical characterisation and Sda activity of GalNAc beta 1-4[NeuAc alpha 2-3]Gal beta 1-4GlcNAc and GalNAc beta 1-4[NeuAc alpha 2-3]Gal beta 1-4Glc.

Authors:  C P Soh; A S Donald; J Feeney; W T Morgan; W M Watkins
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

7.  Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract.

Authors:  T Sareneva; H Holthöfer; T K Korhonen
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

8.  Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli.

Authors:  J Parkkinen; G N Rogers; T Korhonen; W Dahr; J Finne
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

9.  Binding of Escherichia coli S fimbriae to human kidney epithelium.

Authors:  T K Korhonen; J Parkkinen; J Hacker; J Finne; A Pere; M Rhen; H Holthöfer
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 10.  Exploration of the Sialic Acid World.

Authors:  Roland Schauer; Johannis P Kamerling
Journal:  Adv Carbohydr Chem Biochem       Date:  2018-11-28       Impact factor: 12.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.